KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Incyte (INCY) over the last 15 years, with Dec 2024 value amounting to $0.15.

  • Incyte's EPS (Weighted Average and Diluted) rose 290.74% to $2.11 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.90, marking a year-over-year increase of 4114.29%. This contributed to the annual value of $0.15 for FY2024, which is 94.34% down from last year.
  • Incyte's EPS (Weighted Average and Diluted) amounted to $0.15 in FY2024, which was down 94.34% from $2.65 recorded in FY2023.
  • Incyte's EPS (Weighted Average and Diluted)'s 5-year high stood at $4.27 during FY2021, with a 5-year trough of -$1.36 in FY2020.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $1.52 (2022), whereas its average is $1.44.
  • Per our database at Business Quant, Incyte's EPS (Weighted Average and Diluted) plummeted by 166.34% in 2020 and then soared by 413.97% in 2021.
  • Incyte's EPS (Weighted Average and Diluted) (Yearly) stood at -$1.36 in 2020, then soared by 413.97% to $4.27 in 2021, then plummeted by 64.40% to $1.52 in 2022, then soared by 74.34% to $2.65 in 2023, then crashed by 94.34% to $0.15 in 2024.